REG - ConvaTec Group PLC - Notification of major interest in shares <Origin Href="QuoteRef">CTEC.L</Origin>

ConvaTecAnnouncement

31/03/2017 13:50

RNS Number : 2069B
ConvaTec Group PLC
31 March 2017
TR1 NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:ii
CONVATEC GROUP PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation:iii
NORDIC CAPITAL VI LIMITED
NORDIC CAPITAL VII LIMITED
4. Full name of shareholder(s)
(if different from 3.):iv
CIDRON HEALTHCARE TOPCO LIMITED 
CIDRON HEALTHCARE CO-INVEST LIMITED
CIDRON HEALTHCARE CO-INVEST II LIMITED
5. Date of the transaction and date on
which the threshold is crossed or
reached:v
31 MARCH 2017 
6. Date on which issuer notified:
31 MARCH 2017
7. Threshold(s) that is/are crossed or
reached: vi, vii
Below 17%
8. Notified details:
A: Voting rights attached to sharesviii, ix
Class/type of
shares

if possible using
the ISIN CODE
Situation previous
to the triggering
transaction
Resulting situation after the triggering transaction
Number
of
Shares
Number
of
Voting
Rights
Number
of shares
Number of voting
rights
% of voting rights x
Direct
Direct xi
Indirect xii
Direct
Indirect
ORDINARY SHARES OF 0.10 EACH
849,181,983
849,181,983
N/A
314,158,828
N/A
16.10%
GB00BD3VFW73
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument
Expiration
date xiii
Exercise/
Conversion Period xiv
Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.
% of voting
rights
N/A
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument
Exercise price
Expiration date xvii
Exercise/
Conversion period xviii
Number of voting rights instrument refers to
% of voting rights xix, xx
N/A
Nominal
Delta
Total (A+B+C)
Number of voting rights
Percentage of voting rights
314,158,828
16.10%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Nordic Capital VI Limited is the General Partner of Nordic Capital VI Alpha, L.P. and Nordic Capital VI Beta, L.P. (Fund VI) and is responsible for managing Fund VI.
Nordic Capital VII Limited is the General Partner of Nordic Capital VII Alpha, L.P. and Nordic Capital VII Beta, L.P. (Fund VII) and is responsible for managing Fund VII.
Fund VI and Fund VII hold shares in Cidron Healthcare Topco Limited (Topco). Topco in turn holds one management share in each of Cidron Healthcare Co-invest Limited and Cidron Healthcare Co-invest II Limited. 
Proxy Voting:
10. Name of the proxy holder:
N/A
11. Number of voting rights proxy holder will cease
to hold:
N/A
12. Date on which proxy holder will cease to hold
voting rights:
N/A

13. Additional information:
This disclosure has been calculated based on issued share capital of 1,951,472,651 shares as disclosed by ConvaTec Group Plc in its Annual Report and Accounts for the year ended 31 December 2016
14. Contact name:
LYNDA ELLIOTT
15. Contact telephone number:
+ 44 1534 605105

This information is provided by RNS
The company news service from the London Stock Exchange
  END
HOLWGURCWUPMGPG